Related Experiment Video

Updated: May 21, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Small dense LDL: risk factor for coronary artery disease (CAD) and its therapeutic modulation

Suman B Sharma1, Seema Garg

  • 1Department of Biochemistry, University College of Medical Sciences & GTB Hospital, University of Delhi, Delhi 110095, India. drsbs08@hotmail.com

Indian Journal of Biochemistry & Biophysics
|June 2, 2012
PubMed

Insights

Small dense low-density lipoprotein (sdLDL) offers better coronary artery disease (CAD) risk assessment than LDL-C alone. Reviewing sdLDL

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Coronary artery disease (CAD) pathogenesis is multifactorial, involving numerous risk factors.
  • Low-density lipoprotein cholesterol (LDL-C) is a key therapeutic target, but its estimation alone may be insufficient for comprehensive risk assessment.
  • Low-density lipoprotein (LDL) particles exhibit heterogeneity in size, density, and composition, influencing their atherogenic potential.

Purpose of the Study:

  • To review the role of small dense (sd) LDL in assessing CAD risk.
  • To examine the response of sdLDL to various available therapeutic interventions.

Main Methods:

  • Literature review of studies investigating small dense LDL.
  • Analysis of the relationship between sdLDL levels and CAD risk.
  • Evaluation of therapeutic strategies targeting sdLDL.

Main Results:

  • Small dense LDL particles possess distinct physico-chemical properties contributing to increased cardiovascular risk.
  • Standard LDL-C measurements may not fully capture the atherogenic risk associated with sdLDL.
  • Certain therapeutic modalities demonstrate varying efficacy in modifying sdLDL levels.

Conclusions:

  • Small dense LDL is a significant, independent risk factor for coronary artery disease.
  • Incorporating sdLDL assessment into clinical practice may enhance cardiovascular risk stratification.
  • Further research is warranted to optimize therapeutic approaches targeting sdLDL for CAD prevention.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...